On May 1, 2023 (the Termination Date), in connection with the planned closure of the Company's San Diego, CA office, Armata Pharmaceuticals, Inc. (the Company) terminated the employment of Erin Butler as principal financial officer of the Company, effective as of close of business on the Termination Date. On May 4, 2023, the Company's Board of Directors appointed Julianne Averill to serve, effective as of May 2, 2023, as Chief Financial Officer of the Company and in such capacity, also serve as principal financial officer of the Company. Ms. Averill, age 38, has served as a senior director of Danforth Advisors, LLC since August 2021.

Ms. Averill has over 20 years of finance & corporate development leadership experience, providing CFO advisory services and supporting life science organizations with capital raise initiatives, investor relations, and corporate strategy. Prior to Danforth, Ms. Averill held several CFO and other operational executive roles of increasing responsibility at leading public and private companies operating at the intersection of technology and science, including serving as CFO for Alveo Technologies from July 2020 to August 2021; VP Finance & Executive Committee Member for BlackThorn Therapeutics from January 2019 to July 2020; Associate VP, Finance & Accounting, for Manifest MedEx from May 2015 to January 2019, and Director of Financial Reporting for Starwood Waypoint Residential Trust from July 2014 to May 2015. Ms. Averill spent her early career at Deloitte as an audit manager in its life sciences and retail practice.

Ms. Averill is licensed as an active Certified Public Accountant in the State of California and is a Society of Human Resource Management Certified Professional. She holds a BS in Business Administration and an MS in Accountancy, both from California State University, Fresno, and has received a certificate in Business and Data Analytics from Harvard University.